½ÃÀ庸°í¼­
»óǰÄÚµå
1420168

Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ¿¹Ãø(-2030³â) - Áö¿ªº° ºÐ¼® : À¯Çüº°, ¿ëµµº°, °Ë»ç À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®

South & Central America Glucose Monitoring Devices Market Forecast to 2030 - Regional Analysis - By Type, Application, Testing Type, and End User

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 85 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº 2022³â 12¾ï 4,506¸¸ ´Þ·¯¿¡¼­ 2030³â±îÁö 27¾ï 9,505¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2022-2030³â°£ ¿¬Æò±Õ 10.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Ç÷´ç ¸ð´ÏÅ͸µ ÀåÄ¡ÀÇ ±Þ¼ÓÇÑ ±â¼ú ¹ßÀüÀ¸·Î Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ÀåÄ¡ ½ÃÀå ¼ºÀå ÃËÁø

÷´Ü ±â¼úÀÌ Àû¿ëµÈ Á¦Ç°Àº ´ç´¢º´ Ä¡·á¿¡ ÀÖ¾î º¸´Ù È¿°úÀûÀÎ ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ´ç´¢º´ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÷´Ü Á¦Ç°¿¡ ´ëÇÑ ¼ö¿äµµ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ¿¬±¸ÀÚµéÀº ¿À·£ ±â°£ µ¿¾È Á¦Ç° Çõ½ÅÀ» À§ÇÑ ¿¬±¸ Ȱµ¿À» ÇØ¿Ô½À´Ï´Ù. Àν¶¸°À» ü³»¿¡ Åõ¿©ÇÏ´Â ¹æ¹ý¿¡´Â ÁÖ»ç¹Ù´Ã, Àν¶¸° Ææ, Àν¶¸° ÆßÇÁ µîÀÌ ÀÖ½À´Ï´Ù. Àν¶¸° ÆßÇÁ´Â ÇǺΠ¾Æ·¡¿¡ ij´¼¶ó·Î ¿¬°áµÈ ¼ÒÇü ÄÄÇ»ÅÍÈ­µÈ ´ç´¢º´ °ü¸® ÀåÄ¡·Î, Àν¶¸° ¼öÄ¡¸¦ õõÈ÷ Áö¼ÓÀûÀ¸·Î °ø±ÞÇÕ´Ï´Ù. °³ÀÎÀº Çʿ信 µû¶ó ÇÁ·Î±×·¥À» Á¦¾îÇÒ ¼ö ÀÖ½À´Ï´Ù. ÃÖÀûÀÇ ´ç´¢º´ °ü¸®´Â Á¤È®ÇÑ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â¿¡ ´Þ·Á ÀÖ½À´Ï´Ù. Ç÷´ç ¸ð´ÏÅ͸µ ±â±â°¡ ¹ßÀüÇÔ¿¡ µû¶ó ÇÊ¿äÇÑ Ç÷¾×·®ÀÌ ÁÙ¾îµé°í Á¤È®µµ°¡ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. Ç÷´ç ÃøÁ¤±â¿Í Ç÷´ç ¸ð´ÏÅ͸µ ÀåÄ¡ °£ÀÇ µ¥ÀÌÅÍ Àü¼Û ´É·Âµµ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. Ç÷´ç ¸ð´ÏÅ͸µ ±â¼úÀÌ Á¡Á¡ ´õ ¹ßÀüÇÔ¿¡ µû¶ó Á¤È®µµ°¡ Çâ»óµÇ°í ÇÊ¿äÇÑ Ç÷¾×·®ÀÌ ÁÙ¾îµé°í Ç÷´ç ÃøÁ¤±â¿Í Ç÷´ç ¸ð´ÏÅ͸µ ÀåÄ¡ °£ÀÇ µ¥ÀÌÅÍ Àü¼Û ´É·Âµµ Çâ»óµÇ°í ÀÖ½À´Ï´Ù.2022³â 6¿ùAbbott´Â ÇϳªÀÇ ¼¾¼­·Î Æ÷µµ´ç°ú ÄÉÅæ ¼öÄ¡¸¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ´Â »õ·Î¿î ¹ÙÀÌ¿À ¿þ¾î·¯ºíÀ» ¹ßÇ¥Çß½À´Ï´Ù. »õ·Î¿î ¹ÙÀÌ¿À ¿þ¾î·¯ºíÀ» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀü°ú ½ÅÁ¦Ç°ÀÇ À¯ÀÔ Áõ°¡´Â ÇâÈÄ ¸î ³âµ¿¾È ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå °³¿ä

Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ºê¶óÁú, ¾Æ¸£ÇîÆ¼³ª, ±âŸ ³²¹Ì·Î ±¸ºÐµË´Ï´Ù. Áß³²¹Ì ½ÃÀåÀÇ ¼ºÀåÀº ´ç´¢º´ Àα¸°¡ ¸¹±â ¶§¹®ÀÔ´Ï´Ù. ³²¾Æ°øÀº ´ç´¢º´ À¯º´·üÀÌ ³ô±â ¶§¹®¿¡ ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼­ µÎ ¹øÂ°·Î Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¾Õ¼­ ¾ð±ÞÇÑ ¿äÀεéÀº Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¿µÇâ·Â ÀÖ´Â ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ¸ÅÃâ ¹× 2030³â±îÁöÀÇ Àü¸Á

Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ¼¼ºÐÈ­

Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ¼¼ºÐÈ­

Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº À¯Çü, ¿ëµµ, °Ë»ç ºÎÀ§, ÃÖÁ¾ »ç¿ëÀÚ, ±¹°¡º°·Î ¼¼ºÐÈ­µË´Ï´Ù.

À¯Çüº°·Î Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ ±â±â¿Í ÀÚ°¡ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â·Î ºÐ·ùµÇ¸ç, 2022³â Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼­ ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ºÎ¹®ÀÌ Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¬¼ÓÇü Ç÷´ç ¸ð´ÏÅ͸µ ÀåÄ¡ ºÎ¹®ÀÌ Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿ëµµº°·Î Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº 1Çü ´ç´¢º´°ú 2Çü ´ç´¢º´À¸·Î ±¸ºÐµÇ¸ç, 2022³â Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼­ 2Çü ´ç´¢º´ ºÎ¹®ÀÌ Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°Ë»ç ºÎÀ§º°·Î Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ¼Õ°¡¶ô ³¡ °Ë»ç¿Í ´ëü ºÎÀ§ °Ë»ç·Î ¼¼ºÐÈ­µÇ¸ç, 2022³â Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼­ ¼Õ°¡¶ô ³¡ °Ë»ç ºÎ¹®ÀÌ ´õ Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚº°·Î Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ÇコÄɾî ȯ°æ°ú ¼¿ÇÁ/ȨÄÉ¾î ºÎ¹®À¸·Î ±¸ºÐµÇ¸ç, 2022³â Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼­ ¼¿ÇÁ/ȨÄÉ¾î ºÎ¹®ÀÌ Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±¹°¡º°·Î´Â Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ºê¶óÁú, ¾Æ¸£ÇîÆ¼³ª, ±âŸ ³²¹Ì·Î ±¸ºÐµÇ¸ç, 2022³â Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ºê¶óÁúÀÌ ÁÖµµÇß½À´Ï´Ù.

B.Braun SE, F. Hoffmann-La Roche Ltd, Medtronic Plc, Abbott Laboratories, Ypsomed Holding AG, GE HealthCare Technologies Inc µîÀÌ ³²¹Ì ¹× Áß³²¹ÌÀÇ ³²¹Ì ¹× Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³Çϰí ÀÖ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä ÀλçÀÌÆ®

Á¦3Àå Á¶»ç ¹æ¹ý

  • Á¶»ç ¹üÀ§
  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç

Á¦4Àå Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ÁÖ¿ä »ê¾÷ ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ÇâÈÄ µ¿Çâ

Á¦5Àå Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ½ÃÀå ºÐ¼®

  • Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ¸ÅÃâ, 2022³â-2030³â

Á¦6Àå Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - ¸ÅÃâ°ú 2030³â±îÁö ¿¹Ãø : À¯Çüº°

  • Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ¸ÅÃâ Á¡À¯À² : À¯Çüº°, 2022³â¡¤2030³â(%)
  • ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ ±â±â
  • ÀÚ±â Ç÷´ç ¸ð´ÏÅ͸µ µð¹ÙÀ̽º

Á¦7Àå Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - ¸ÅÃâ°ú 2030³â±îÁö ¿¹Ãø : ¿ëµµº°

  • Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ¸ÅÃâ Á¡À¯À² : ¿ëµµº°, 2022³â¡¤2030³â(%)
  • 1Çü ´ç´¢º´
  • 2Çü ´ç´¢º´

Á¦8Àå Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - ¸ÅÃâ°ú 2030³â±îÁö ¿¹Ãø : °Ë»ç ºÎÀ§º°

  • Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ¸ÅÃâ Á¡À¯À² : °Ë»ç ºÎÀ§º°, 2022³â¡¤2030³â(%)
  • ¼Õ°¡¶ô³¡ °Ë»ç
  • ´ëü ºÎÀ§ °Ë»ç

Á¦9Àå Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - ¸ÅÃâ°ú 2030³â±îÁö ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°

  • Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ¸ÅÃâ Á¡À¯À² : ÃÖÁ¾»ç¿ëÀÚº°, 2022³â¡¤2030³â(%)
  • ÇコÄɾî
  • Àڱ⠰ǰ­ °ü¸®/ȨÄɾî

Á¦10Àå Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - ¸ÅÃâ°ú 2030³â±îÁö ¿¹Ãø : ±¹°¡º° ºÐ¼®

  • Áß³²¹Ì : Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå

Á¦11Àå ¾÷°è »óȲ

  • Áß³²¹ÌÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ¼ºÀå Àü·«
  • À¯±âÀû Àü°³
  • ¹«±âÀû Àü°³

Á¦12Àå ±â¾÷ °³¿ä

  • B. Braun SE
  • F. Hoffmann-La Roche Ltd
  • Medtronic Plc
  • Abbott Laboratories
  • Ypsomed Holding AG
  • GE HealthCare Technologies Inc

Á¦13Àå ºÎ·Ï

LSH 24.02.16

The South & Central America glucose monitoring devices market is expected to grow from US$ 1,245.06 million in 2022 to US$ 2,795.05 million by 2030. It is estimated to grow at a CAGR of 10.6% from 2022 to 2030.

Rapid Technological Advancements in Glucose Monitoring Devices Fuel South & Central America Glucose Monitoring Devices Market

Products with advanced technologies offer more effective benefits in diabetes treatment. As the prevalence of diabetes increases worldwide, the demand for more products with advancements also accelerates. Thus, researchers have been carrying out research activities resulting in product innovations over the years. There are many methods to deliver insulin into the body, such as needles, insulin pens, and insulin pumps. Insulin pumps are small, computerized diabetes management devices connected with a cannula under the skin to deliver a slow, continuous insulin level. The individual can control the program depending on the requirements. Optimal diabetes management depends on accurate glucose monitoring devices. The increasing advancements in glucose monitoring devices have resulted in smaller required blood volumes with improved accuracy. The ability to transfer data between the blood glucose meter and glucose monitoring devices has also been improved. The increasing advancements in blood glucose monitoring technology have improved accuracy, smaller required blood volumes, and the ability to transfer data between the blood glucose meter and glucose monitoring devices. In June 2022, Abbott announced a new bio wearable that continuously monitors glucose and ketone levels in one sensor. Thus, the technological advancements coupled with the increasing influx of new products are expected to propel the market growth over the forecast years.

South & Central America Glucose Monitoring Devices Market Overview

The South & Central America glucose monitoring devices market has been segmented into the Brazil, Argentina, and Rest of South & Central America. The market growth in South & Central America is high attributed to the big pool of diabetic population in the country. South Africa holds second largest share in terms of continuous glucose monitoring owing to high prevalence of diabetes in the country. The aforementioned factors are responsible for influential growth of glucose monitoring devices market in the South & Central America region.

South & Central America Glucose Monitoring Devices Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Glucose Monitoring Devices Market Segmentation

The South & Central America glucose monitoring devices market is segmented into type, application, testing site, end- user, and country.

Based on type, the South & Central America glucose monitoring devices market is segmented into continuous glucose monitoring devices and self-glucose monitoring devices. The continuous glucose monitoring devices segment held a larger share of the South & Central America glucose monitoring devices market in 2022.

Based on application, the South & Central America glucose monitoring devices market is segmented into type 1 diabetes and type 2 diabetes. The type 2 diabetes segment held a larger share of the South & Central America glucose monitoring devices market in 2022.

Based on testing site, the South & Central America glucose monitoring devices market is segmented into fingertip testing and alternate site testing. The fingertip testing segment held a larger share of the South & Central America glucose monitoring devices market in 2022.

Based on end user, the South & Central America glucose monitoring devices market is segmented into healthcare setting and self/homecare. The self/homecare segment held a larger share of the South & Central America glucose monitoring devices market in 2022.

Based on country, the South & Central America glucose monitoring devices market is segmented int o Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America glucose monitoring devices market in 2022.

B. Braun SE, F. Hoffmann-La Roche Ltd, Medtronic Plc, Abbott Laboratories, Ypsomed Holding AG, and GE HealthCare Technologies Inc are some of the leading companies operating in the South & Central America glucose monitoring devices market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America glucose monitoring devices market.
  • Highlights key business priorities to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in South & Central America glucose monitoring devices market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Glucose Monitoring Devices Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Rising Incidence of Diabetes
    • 4.1.2 Growing Geriatric Population
    • 4.1.3 Increasing Prevalence of Obesity
  • 4.2 Key Market Restraints
    • 4.2.1 High Cost of Glucose Monitoring Devices
  • 4.3 Key Market Opportunities
    • 4.3.1 Growing Medical Tourism in Developing Countries
  • 4.4 Future Trends
    • 4.4.1 Rapid Technological Advancements in Glucose Monitoring Devices

5. South & Central America Glucose Monitoring Devices Market - Market Analysis

  • 5.1 South & Central America Glucose Monitoring Devices Market Revenue (US$ Mn), 2022 - 2030

6. Glucose Monitoring Devices Market - Revenue and Forecast to 2030 - by Type

  • 6.1 Overview
  • 6.2 South & Central America Glucose Monitoring Devices Market Revenue Share, by Type 2022 & 2030 (%)
  • 6.3 Continuous Glucose Monitoring Devices
    • 6.3.1 Overview
    • 6.3.2 Continuous Glucose Monitoring Devices: South & Central America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 Sensors
        • 6.3.2.1.1 Sensors: South & Central America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.2 Transmitters
        • 6.3.2.2.1 Transmitters: South & Central America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.3 Receivers
        • 6.3.2.3.1 Receivers: South & Central America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Self-Glucose Monitoring Devices
    • 6.4.1 Overview
    • 6.4.2 Self-Glucose Monitoring Devices: South & Central America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.1 Testing Strips
        • 6.4.2.1.1 Testing Strips: South & Central America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.2 Glucose Meters
        • 6.4.2.2.1 Glucose Meters: South & Central America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.3 Lancets
        • 6.4.2.3.1 Lancets: South & Central America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.4 Others
        • 6.4.2.4.1 Others: South & Central America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)

7. Glucose Monitoring Devices Market - Revenue and Forecast to 2030 - by Application

  • 7.1 Overview
  • 7.2 South & Central America Glucose Monitoring Devices Market Revenue Share, by Application 2022 & 2030 (%)
  • 7.3 Type 1 Diabetes
    • 7.3.1 Overview
    • 7.3.2 Type 1 Diabetes: South & Central America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Type 2 Diabetes
    • 7.4.1 Overview
    • 7.4.2 Type 2 Diabetes: South & Central America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. Glucose Monitoring Devices Market - Revenue and Forecast to 2030 - by Testing Site

  • 8.1 Overview
  • 8.2 South & Central America Glucose Monitoring Devices Market Revenue Share, by Testing Site 2022 & 2030 (%)
  • 8.3 Fingertip Testing
    • 8.3.1 Overview
    • 8.3.2 Fingertip Testing: South & Central America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Alternate Site Testing
    • 8.4.1 Overview
    • 8.4.2 Alternate Site Testing: South & Central America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. Glucose Monitoring Devices Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 South & Central America Glucose Monitoring Devices Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Healthcare Settings
    • 9.3.1 Overview
    • 9.3.2 Healthcare Settings: South & Central America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Self/Homecare
    • 9.4.1 Overview
    • 9.4.2 Self/Homecare: South & Central America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 -Country Analysis

  • 10.1 South & Central America: Glucose Monitoring Devices Market
    • 10.1.1 Overview
    • 10.1.2 South & Central America: Glucose Monitoring Devices Market, by Country
      • 10.1.2.1 Brazil: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 Brazil: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.1.3 Brazil: Glucose Monitoring Devices Market, by Type, 2020-2030 (US$ Million)
        • 10.1.2.1.3.1 Brazil: Glucose Monitoring Devices Market, For Continuous Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
        • 10.1.2.1.3.2 Brazil: Glucose Monitoring Devices Market, For Self-Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
        • 10.1.2.1.4 Brazil: Glucose Monitoring Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.1.5 Brazil: Glucose Monitoring Devices Market, by Testing Site, 2020-2030 (US$ Million)
        • 10.1.2.1.6 Brazil: Glucose Monitoring Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.2 Argentina: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Argentina: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.2.3 Argentina: Glucose Monitoring Devices Market, by Type, 2020-2030 (US$ Million)
        • 10.1.2.2.3.1 Argentina: Glucose Monitoring Devices Market, For Continuous Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
        • 10.1.2.2.3.2 Argentina: Glucose Monitoring Devices Market, For Self-Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
        • 10.1.2.2.4 Argentina: Glucose Monitoring Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.2.5 Argentina: Glucose Monitoring Devices Market, by Testing Site, 2020-2030 (US$ Million)
        • 10.1.2.2.6 Argentina: Glucose Monitoring Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.3 Rest of South & Central America: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 Rest of South & Central America: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.3.3 Rest of South & Central America: Glucose Monitoring Devices Market, by Type, 2020-2030 (US$ Million)
        • 10.1.2.3.3.1 Rest of South & Central America: Glucose Monitoring Devices Market, For Continuous Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
        • 10.1.2.3.3.2 Rest of South & Central America: Glucose Monitoring Devices Market, For Self-Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
        • 10.1.2.3.4 Rest of South & Central America: Glucose Monitoring Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.3.5 Rest of South & Central America: Glucose Monitoring Devices Market, by Testing Site, 2020-2030 (US$ Million)
        • 10.1.2.3.6 Rest of South & Central America: Glucose Monitoring Devices Market, by End User, 2020-2030 (US$ Million)

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the South & Central America Glucose Monitoring Devices Market
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 B. Braun SE
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 F. Hoffmann-La Roche Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Medtronic Plc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Abbott Laboratories
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Ypsomed Holding AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 GE HealthCare Technologies Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦